The health and economic burden of respiratory syncytial virus associated hospitalizations in adults.

Namrata PrasadE Claire NewbernAdrian A TrenholmeMark G ThompsonColin McArthurConroy A WongLauren JelleyNayyereh AminisaniQ Sue HuangCameron C Grant

Published in: PloS one (2020)

RSV infection is associated with considerable disease and economic cost in adults. RSV disproportionally affects adult sub-groups defined by age, ethnicity, and neighborhood SES. An effective RSV vaccine or RSV treatment may offer benefits for older adults.

Keyphrases

respiratory syncytial virus
physical activity
healthcare
public health
young adults
climate change
combination therapy
health promotion